Journal profile · INTEGRATIVE & COMPLEMENTARY MEDICINE-PHARMACOLOGY & PHARMACY
Chinese Journal of Natural Medicines
ISSN 2095-6975 · eISSN 1875-5364 · China Pharmaceutical University · PEOPLES R CHINA · Bi-monthly · Founded 2003
Chinese Journal of Natural Medicines: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 7.47; hybrid open access; APC about USD 3,000; median 127 days to acceptance (108 articles, last 24 months); 133 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Chinese Journal of Natural Medicines is published by China Pharmaceutical University and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Natural product bioactivities and synthesis, Phytochemistry and Biological Activities and Traditional Chinese Medicine Analysis, together about 34.9% of its articles. Its main subfields are Pharmacology. (generated from OpenAlex topic counts and CAS ranking data)
The Chinese Journal of Natural Medicines (CJNM), founded and sponsored in May 2003 by China Pharmaceutical University and the Chinese Pharmaceutical Association, is devoted to communication among pharmaceutical and medical scientists interested in the advancement of Traditional Chinese Medicines (TCM). CJNM publishes articles relating to a broad spectrum of bioactive natural products, leading compounds and medicines derived from Traditional Chinese Medicines (TCM).Topics covered by the journal are: Resources of Traditional Chinese Medicines; Interaction and complexity of prescription; Natural Products Chemistry (including structure modification, semi-and total synthesis, bio-transformation); Pharmacology of natural products and prescription (including pharmacokinetics and toxicology); Pharmaceutics and Analytical Methods of natural products.Authors should submit their manuscripts online at http://mc03.manuscriptcentral.com/cjnm, or by email to the Editorial Office, China Pharmaceutical University, at cjnm@yahoo.cn.
From the journal's Aims & Scope
Research area (LetPub): INTEGRATIVE & COMPLEMENTARY MEDICINE-PHARMACOLOGY & PHARMACY
Editor-in-chief Ling-Yi KongPublisher website
Editorial board by country: 63 in mainland China (about 67%); most named Mainland China 63, United States 5, United Kingdom 3, Macau, China 2, Japan 2 (94 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Natural product bioactivities and synthesisBiochemistry, Genetics and Molecular Biology15.5%
- Phytochemistry and Biological ActivitiesAgricultural and Biological Sciences11.3%
- Traditional Chinese Medicine AnalysisMedicine8.1%
- Pharmacological Effects of Natural CompoundsPharmacology, Toxicology and Pharmaceutics7.3%
- Traditional Chinese Medicine StudiesMedicine4.5%
- Microbial Natural Products and BiosynthesisMedicine4.4%
- Ginseng Biological Effects and ApplicationsBiochemistry, Genetics and Molecular Biology3.8%
- Chromatography in Natural ProductsChemistry3.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Integrative & Complementary Medicine | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Integrative & Complementary Medicine | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 1 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Integrative & Complementary Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 7.47LetPub ·
- Impact factor (publisher)
- 7.5Publisher website ·
- CiteScore 2026-06
- 7.7LetPub ·
- CiteScore (publisher)
- 7.7Publisher website ·
- SJR 2026-06
- 1.1LetPub ·
- SNIP 2026-06
- 1.27LetPub ·
- h-index
- 27LetPub ·
- h-index
- 60OpenAlex ·
- i10-index
- 1,127OpenAlex ·
- 2-year mean citedness
- 4.14OpenAlex ·
- Self-citation rate
- 8%LetPub ·
- Share of gold OA articles
- 7.54%LetPub ·
Volume
- Articles per year
- 132LetPub ·
Articles by year OpenAlex count · 3,357 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 88 | 7 | 20 |
| 2025 | 133 | 17 | 434 |
| 2024 | 106 | 2 | 901 |
| 2023 | 91 | 6 | 1,269 |
| 2022 | 89 | 4 | 934 |
| 2021 | 97 | 2 | 2,026 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
127 daysMedian, submission to acceptance · P25–P75 93 days – 153 days
- Acceptance to online
- median 20 days (10 articles)
- Submission to online
- median 436 days
- Sample
- 108 articles with submission and acceptance dates (249 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision
- 1 daysPublisher website ·
- Submission to acceptance
- 417 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,000 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Reference style
- Numbered, in order of citation
- Highlights
- Optional
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
1 to 7 keywords required Model summary
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Peer review Peer review
Double anonymized peer review Model summary
This journal follows a double anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- China Pharmaceutical University
- Country or region
- PEOPLES R CHINA
- Language
- English
- Frequency
- Bi-monthly
- Founded
- 2003
- ISSN
- 2095-6975
- Electronic ISSN
- 1875-5364
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Chinese Journal of Natural Medicines
What CAS zone is Chinese Journal of Natural Medicines in?
In the 2025 upgraded edition of the CAS Journal Ranking, Chinese Journal of Natural Medicines is in Zone 2 of Medicine, and in Zone 2 of the minor category Integrative & Complementary Medicine / Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Chinese Journal of Natural Medicines?
The latest impact factor listed by LetPub is 7.47; CiteScore 7.7, h-index 60.
How long does peer review take at Chinese Journal of Natural Medicines?
Based on the dates recorded on 108 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 127 days (interquartile range 93–153 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Chinese Journal of Natural Medicines?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Reference style: Numbered, in order of citation; Highlights: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Chinese Journal of Natural Medicines based?
Of the 94 board members whose country the journal's board page names, 63 (about 67%) are in mainland China; the countries named most often are Mainland China (63), United States (5) and United Kingdom (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Chinese Journal of Natural Medicines?
According to LetPub and DOAJ records, Chinese Journal of Natural Medicines is indexed in SCIE and Scopus.
Is Chinese Journal of Natural Medicines open access, and what is the APC?
Chinese Journal of Natural Medicines is a hybrid journal. For open-access publication: APC about USD 3,000.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .